Nasdaq
$3.82▼ 1.29%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $14.9MShares out 3.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
8- 8.19After-hours26.08.20 06:078-KKey event#●●●
REVELATION BIOSCIENCES, INC.
On August 17, 2026, Revelation Biosciences, Inc. granted Restricted Stock Awards of 208,076 shares to CEO James Rolke and 208,073 shares to CFO Chester S. Zygmont. The awards vest in four equal tranches contingent upon the company achieving market capitalization milestones ranging from $30 million to $120 million or upon the passage of specified time periods.…more
$3.82-1.29%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.18After-hours26.08.19 06:004Ownership
REVELATION BIOSCIENCES, INC.
James Rolke, an executive at Revelation Biosciences, Inc. (REVB), filed a Form 4 on August 18, 2026, regarding changes in beneficial ownership of securities as of August 17, 2026. This filing serves as an official record of insider equity transactions.…more
$3.82-1.29%vs prev closeView filingShare - 8.18After-hours26.08.19 06:004Ownership
REVELATION BIOSCIENCES, INC.
Lakhmir S. Chawla, an insider at Revelation Biosciences, Inc., reported a change in beneficial ownership of company securities on August 17, 2026. This filing serves as a Form 4 notification regarding the insider's updated equity position.…more
$3.82-1.29%vs prev closeView filingShare
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 4d agoPre-market26.10.20 21:55
Trading Halt Update: Quotation Resumption Following News
The trading halt for the specific security has been lifted and quotation has resumed. This follows the release of news regarding the company.…more
$3.82-1.29%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 5d agoAfter-hours26.10.20 08:50
●●●●●●●● ●●●●● ●●●●●●
Trading for this stock has been temporarily halted pending the release of material news. Investors should monitor for upcoming announcements to assess the impact.…more
$3.82-1.29%vs prev closeShareBenzinga - 10.16Pre-market26.10.16 22:03
●●●●●●●● ●●●●● ●●●●●●
Revelation Biosciences will implement a 1-for-7 reverse stock split of its common stock effective October 20, 2026. The company's shares will continue to trade under the ticker symbol REVB on a post-split basis.…more
$3.82-1.29%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report